Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

被引：3
|
作者：
Smedby, Karin Ekstrom Ekstroem [1 ,2 ]
Ekberg, Sara [2 ]
Eloranta, Sandra [2 ]
Enblad, Gunilla [3 ]
Jerkeman, Mats [4 ]
Andersson, Per-Ola
Harrysson, Sara [2 ,5 ]
机构：
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden
[3] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[4] Lund Univ, Inst Clin Sci, Dept Pathol & Oncol, Lund, Sweden
[5] Karolinska Univ Hosp, Dept Hematol, Solna, Sweden
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123785
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4111
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis
    Gong, Inna
    Crump, Michael
    Prica, Anca
    Calzavara, Andrew
    Liu, Ning
    Rodin, Danielle
    Hodgson, David
    Mozessohn, Lee
    Cheung, Matthew C.
    Kuruvilla, John
    BLOOD, 2024, 144 : 3092 - 3093
  • [42] NEW TREATMENT FOR RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2021, 121 (06) : 21 - 22
  • [43] Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphoma
    Usta, Sila
    Misura, Alexandra
    Rashedi, Iran
    Amitai, Irina
    Roos, Kim
    Jiang, Yidi
    Mangoff, Kathryn
    Klein, Gail
    Forward, Nicholas
    Stewart, Douglas
    Mangel, Joy
    Tomlinson, George
    Tsui, Hubert
    Berinstein, Neil L.
    LEUKEMIA & LYMPHOMA, 2025, 66 (01) : 84 - 94
  • [44] Neurolymphomatosis as the main presentation of relapse of extranodal diffuse large B-cell lymphoma (DLBCL)
    Campagnolo, Marta
    Cacciavillani, Mario
    Cavallaro, Tiziana
    Ferrari, Sergio
    Pavan, Laura
    Barila, Gregorio
    Salvalaggio, Alessandro
    Castellani, Francesca
    Zambello, Renato
    Briani, Chiara
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 557 - 558
  • [45] Outcome following multiple lines of salvage chemotherapy prior to autologous stem cell transplant for relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Stakiw, J.
    Kuruvilla, J.
    Al-Farsi, K.
    Zadeh, S.
    Nagy, T.
    Keating, A.
    Crump, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
    Yung, Mallory
    Schnell, Frederick
    Vukcevic, Mirko
    Kurukulasuriya, Nuwan C.
    BLOOD, 2021, 138 : 1928 - +
  • [47] BCL-Xl Expression Is Druggable Biomarker Associated with a Poor Clinical Outcome in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
    Gu, Juan J.
    Vacaro, Michael
    Attwood, Kris
    Mavis, Cory
    Torka, Pallawi
    Barth, Matthew J.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2019, 134
  • [48] Efficacy of Palliative Radiation Therapy (RT) for Chemotherapy Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review
    Wong, Jordan
    Pickles, Tom
    Connors, Joseph
    Aquino-Parsons, Christina
    Sehn, Laurie
    Freeman, Ciara
    DeVries, Kim
    Lo, Andrea
    PRACTICAL RADIATION ONCOLOGY, 2021, 11 (02) : E203 - E209
  • [49] Comparison of salvage therapies for relapsed or refractory diffuse large B-cell lymphoma (DLBCL): Network meta-analysis.
    Vosuri, Venkata
    Kaisreddy, Ravi
    Bandi, Somasekhar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Flinn, Ian W.
    Bartlett, Nancy L.
    Blum, Kristie A.
    Ardeshna, Kirit M.
    LaCasce, Ann S.
    Flowers, Christopher R.
    Shustov, Andrei R.
    Thress, Kenneth S.
    Mitchell, Patrick
    Zheng, Fred
    Skolnik, Jeffrey M.
    Friedberg, Jonathan W.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : 11 - 17
12345